Global Hormone Replacement Therapy Market Report and Forecast 2024-2032

Global Hormone Replacement Therapy Market Outlook

The global hormone replacement therapy market attained a value of USD 5.50 billion in 2023 and is projected to reach USD 10.00 billion by 2032, growing at a CAGR of 6.9% over the forecast period of 2024-2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on the product type, the oestrogen replacement therapy segment held the majority of the market share in 2020. Based on the route of administration, the parenteral segment is estimated to be the leading segment, accounting for the majority of the market share, followed by oral and transdermal methods.

Regionally, the market is segmented into North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America was the largest market in 2020, accounting for the majority of the market share.

Properties and Applications 

Hormone replacement therapy (HRT) is a treatment used for replenishing the hormones which are present in low levels in the human body. This therapy is particularly favourable for the patients having a deficiency of growth hormone, women in menopausal transition, and geriatric suffering from hypogonadism. It is available in several forms, such as gels, skin, and mouth patches (transdermal), injections, and implants. It is also considered to be a more efficient treatment in comparison to its alternatives, such as chemical drugs, herbal medicines, and others.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The major product types of the market are:

• Oestrogen Replacement Therapy
• Human Growth Hormone Replacement Therapy
• Thyroid Replacement Therapy
• Testosterone Replacement Therapy
• Others

On the basis of route of administration, the industry can be segmented into:

• Oral
• Parenteral
• Transdermal

Based on the type of diseases, the market is divided into:

• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Others

The EMR report looks into the regional markets like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis 

A rise in the incidences of hormonal imbalance disorders in the neonatal and geriatric populations is primarily driving the market growth. HRT is effective for the treatment of the symptoms of menopause such as night sweats, hot flashes, vaginal dryness, and sexual function. Additionally, it minimises the risk of cardiovascular diseases, vasomotor symptoms, colorectal cancer, and osteoporosis while improving the quality of life. Furthermore, advancements in technology such as the introduction of transdermal drug delivery and new gel-based formulations, coupled with increased investments in research and development activities by the manufacturers are providing a boost to the market growth. Moreover, increasing awareness among the consumers, ageing population, sedentary lifestyles, and the presence of regularly monitored formulations are further expected to stimulate the demand for hormone replacement therapy during the forecast period.

Competitive Landscape 

The report presents a detailed analysis of the following key players in the global hormone replacement therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Novo Nordisk A/S
• Abbott Laboratories Inc.
• Pfizer Inc
• Allergan
• Bayer AG
• Merck & Co., Inc.
• Viatris Inc.
• Eli Lilly and Company
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Ltd. (Genentech)
• Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
• ASCEND Therapeutics US, LLC. (Besins Healthcare)
• AbbVie Inc.

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

Hormone Replacement Therapy Market Report Snapshots

Hormone Replacement Therapy Market Size

Hormone Replacement Therapy Companies